Correction to Lancet Diabetes Endocrinol 2017; 5: 864-76

No authors listed

Published Erratum

No authors listed. Lancet Diabetes Endocrinol. 2017 Dec.

. 2017 Dec;5(12):e8.

doi: 10.1016/S2213-8587(17)30375-3.

No abstract available

Erratum for

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Dandona P, Mathieu C, Phillip M, Hansen L, Griffen SC, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators. Dandona P, et al. Lancet Diabetes Endocrinol. 2017 Nov;5(11):864-876. doi: 10.1016/S2213-8587(17)30308-X. Epub 2017 Sep 14. Lancet Diabetes Endocrinol. 2017. PMID: 28919061 Clinical Trial.